# EDGAR Filing Document

**Accession Number:** 0001814423
**File Stem:** 0001104659-23-039618
**Filing Date:** 2023-3
**Character Count:** 29384
**Document Hash:** 1998f54dcd3973de81ed527bee218f04
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-039618.hdr.sgml**: 20230331

**ACCESSION NUMBER**: 0001104659-23-039618

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20230331

**FILED AS OF DATE**: 20230331

**DATE AS OF CHANGE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iHuman Inc.
- **CENTRAL INDEX KEY:** 0001814423
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-EDUCATIONAL SERVICES [8200]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39591
- **FILM NUMBER:** 23783255

**BUSINESS ADDRESS:**
- **STREET 1:** FLOOR 8, BUILDING 2,
- **STREET 2:** NO.1 WANGJING EAST RD, CHAOYANG DISTRICT
- **CITY:** BEIJING
- **STATE:** F4
- **ZIP:** 100102
- **BUSINESS PHONE:** 86-10-5780-6636

**MAIL ADDRESS:**
- **STREET 1:** FLOOR 8, BUILDING 2,
- **STREET 2:** NO.1 WANGJING EAST RD, CHAOYANG DISTRICT
- **CITY:** BEIJING
- **STATE:** F4
- **ZIP:** 100102

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16 UNDER**

**THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of March 2023**

**Commission File Number: 001-39591**

**iHuman Inc.**

(Registrant's Name)

**Floor 8, Building B,<br> No. 1 Wangjing East Road,<br> Chaoyang District, Beijing 100102**

**People's Republic of China**

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ⌧ Form 40-F ◻

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | &nbsp;&nbsp;**Description** |
| &nbsp;&nbsp;[99.1](tm2311136d1_ex99-1.htm) | [Press Release](tm2311136d1_ex99-1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| **iHuman Inc.** | **iHuman Inc.** | **iHuman Inc.** |
| By | : | /s/ Vivien Weiwei Wang |
| Name | : | Vivien Weiwei Wang |
| Title | : | Director and Chief Financial Officer |

---

Date: March 31, 2023

## Exhibit 99.1

**Exhibit 99.1**

![](tm2311136d1_ex99-1img001.jpg)

**iHuman Inc.** **Announces Fourth Quarter and Fiscal Year 2022 Unaudited Financial Results**

BEIJING, China, March 31, 2023 -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2022.

**<u>Fourth Quarter 2022 Highlights</u>**

• Revenues reached a record-high of RMB260.7 million (US$37.8 million), compared with RMB237.8 million in
the same period last year.

• Gross profit was RMB181.0 million (US$26.2 million), compared with RMB164.9 million in the same period
last year.

• Operating income was RMB39.1 million (US$5.7 million), a remarkable turnaround compared with an operating
loss of RMB10.6 million in the same period last year.

• Adjusted operating income <sup>1</sup> was RMB44.2 million (US$6.4 million), a remarkable turnaround compared with an adjusted operating loss of RMB9.0 million in the same period
last year.

• Net income was RMB35.4 million (US$5.1 million), a remarkable turnaround compared with a net loss of RMB7.9
million in the same period last year.

• Adjusted net income<sup>1</sup> was RMB40.5 million (US$5.9 million), a remarkable turnaround compared
with an adjusted net loss of RMB6.4 million in the same period last year.

• Average total MAUs <sup>2</sup> reached a record-high of 22.22 million, a year-over-year increase of 35.9%.

• Number of paying users <sup>3</sup> reached a record-high of 1.75 million, a year-over-year increase of 23.9%.

**<u>Fiscal Year 2022 Highlights</u>**

• Revenues were RMB985.5 million (US$142.9 million), compared with RMB944.7 million in fiscal year 2021.

• Gross profit was RMB691.2 million (US$100.2 million), compared with RMB660.6 million in fiscal year 2021.

• Operating income was RMB111.6 million (US$16.2 million), a remarkable turnaround compared with an operating
loss of RMB54.2 million in fiscal year 2021.

• Adjusted operating income was RMB124.6 million (US$18.1 million), a remarkable turnaround compared with
an adjusted operating loss of RMB39.1 million in fiscal year 2021.

• Net income was RMB109.8 million (US$15.9 million), a remarkable turnaround compared with a net loss of
RMB37.1 million in fiscal year 2021.

• Adjusted net income was RMB122.9 million (US$17.8 million), a remarkable turnaround compared with an adjusted
net loss of RMB21.9 million in fiscal year 2021.

• Average total MAUs for fiscal year 2022 were 19.86 million.

• Number of paying users for fiscal year 2022 was 4.75 million.

<sup>1</sup> "Adjusted operating income (loss)" and "adjusted net income (loss)" exclude share-based compensation expenses. Please see "Non-GAAP Financial Measures" and "Unaudited Reconciliation of GAAP and non-GAAP Results" at the end of this press release.

<sup>2</sup> "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

<sup>3</sup> "Paying users" refers to users who paid subscription fees for premium content on any of the Company's apps during a specific period; a user who makes payments across different apps using the same registered account is counted as one paying user, and a user who makes payments for the same app multiple times in the same period is counted as one paying user.

Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "We are excited to report another robust quarter, reaching several new record-highs during the period. We delivered all-time high revenues of RMB260.7 million in the fourth quarter, representing an increase of 9.6% year-over-year. This result reflects the strong appeal of our diversified portfolio and the solid execution capabilities of our team. More importantly, we achieved our fourth consecutive quarter of profitability during the year. Our fourth quarter operating income reached a record-high, and net income reached RMB35.4 million, a remarkable turnaround from the same period last year. The sustained improvement in profitability also resulted in our first annual profit since our initial public offering in 2020. In addition, we maintained a strong balance sheet and healthy operating cash flow, with cash and cash equivalents exceeding RMB1 billion as of the year end. This provides us with the means and flexibility to invest in technological and product innovation and pursue attractive opportunities to propel our continued growth. On the user front, we saw notable expansion in the scale of our communities. Our average total MAUs continued on an upward trajectory, hitting another record high of 22.22 million, an increase of 35.9% year-over-year. This reflects the effective execution of our user acquisition strategy. As we enter the new year, we have a demonstrated track record of delivering on our objectives and the confidence to build upon the momentum we achieved in 2022. Looking ahead, we will continue to invest in key strategic initiatives while maintaining our financial discipline and operational excellence."

**<u>Fourth Quarter 2022 Unaudited Financial Results</u>**

***Revenues***

Revenues were RMB260.7 million (US$37.8 million), an increase of 9.6% from RMB237.8 million in the same period last year, primarily driven by user expansion and enhanced user engagement.

Average total MAUs for the quarter were 22.22 million, an increase of 35.9% year-over-year from 16.35 million in the same period last year. The number of paying users was 1.75 million.

***Cost of Revenues***

Cost of revenues was RMB79.7 million (US$11.6 million), an increase of 9.3% from RMB72.9 million in the same period last year, primarily due to an increase in channel costs, which was in line with the Company's revenue expansion.

***Gross Profit and Gross Margin***

Gross profit was RMB181.0 million (US$26.2 million), an increase of 9.8% from RMB164.9 million in the same period last year. Gross margin was 69.4%, compared with 69.3% in the same period last year.

***Operating Expenses***

Total operating expenses were RMB141.9 million (US$20.6 million), a decrease of 19.2% from RMB175.5 million in the same period last year.

Research and development expenses were RMB66.8 million (US$9.7 million), a decrease of 38.8% from RMB109.1 million in the same period last year, primarily due to payroll-related cost savings and decreased outsourcing expenses.

Sales and marketing expenses were RMB45.8 million (US$6.6 million), an increase of 25.0% from RMB36.7 million in the same period last year, primarily due to increased strategic investments in seasonal promotional activities.

General and administrative expenses were RMB29.3 million (US$4.2 million), a decrease of 1.7% from RMB29.8 million in the same period last year.

***Operating*** ***Income***

Operating income was RMB39.1 million (US$5.7 million), compared with an operating loss of RMB10.6 million in the same period last year.

Excluding share-based compensation expenses, adjusted operating income was RMB44.2 million (US$6.4 million), compared with an adjusted operating loss of RMB9.0 million in the same period last year.

***Net Income***

Net income was RMB35.4 million (US$5.1 million), compared with a net loss of RMB7.9 million in the same period last year.

Adjusted net income was RMB40.5 million (US$5.9 million), compared with an adjusted net loss of RMB6.4 million in the same period last year.

Basic and diluted net income per ADS were RMB0.67 (US$0.10) and RMB0.66 (US$0.10), respectively, compared with basic and diluted net loss per ADS of RMB0.15 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

Adjusted diluted net income per ADS was RMB0.75 (US$0.11), compared with an adjusted diluted net loss per ADS of RMB0.12 in the same period last year.

***Deferred*** ***Revenue and Customer Advances***

Deferred revenue and customer advances were RMB379.1 million (US$55.0 million) as of December 31, 2022, compared with RMB303.0 million as of December 31, 2021.

***Cash and Cash Equivalents***

Cash and cash equivalents were RMB1,050.0 million (US$152.2 million) as of December 31, 2022, compared with RMB855.4 million as of December 31, 2021.

**<u>Fiscal Year 2022 Unaudited Financial Results</u>**

***Revenues***

Revenues were RMB985.5 million (US$142.9 million), an increase of 4.3% from RMB944.7 million in fiscal year 2021.

Average total MAUs were 19.86 million, an increase of 21.1% year-over-year from 16.40 million in fiscal year 2021. The number of paying users for the year was 4.75 million.

***Cost of Revenues***

Cost of revenues was RMB294.3 million (US$42.7 million), an increase of 3.6% from RMB284.1 million in fiscal year 2021.

***Gross Profit and Gross Margin***

Gross profit was RMB691.2 million (US$100.2 million), an increase of 4.6% from RMB660.6 million in fiscal year 2021. Gross margin was 70.1%, compared with 69.9% in fiscal year 2021.

***Operating Expenses***

Total operating expenses were RMB579.6 million (US$84.0 million), a decrease of 18.9% from RMB714.9 million in fiscal year 2021.

Research and development expenses were RMB313.5 million (US$45.5 million), a decrease of 24.5% from RMB415.3 million in fiscal year 2021, primarily due to payroll-related cost savings and decreased outsourcing expenses.

Sales and marketing expenses were RMB156.9 million (US$22.8 million), a decrease of 22.4% from RMB202.1 million in fiscal year 2021, primarily due to a cost-effective and optimized advertising strategy.

General and administrative expenses were RMB109.2 million (US$15.8 million), an increase of 12.1% from RMB97.4 million in fiscal year 2021, primarily due to expenses related to upgrading the Company's corporate governance and compliance structure as a publicly listed company.

***Operating*** ***Income***

Operating income was RMB111.6 million (US$16.2 million), compared with an operating loss of RMB54.2 million in fiscal year 2021.

Excluding share-based compensation expenses, adjusted operating income was RMB124.6 million (US$18.1 million), compared with an adjusted operating loss of RMB39.1 million in fiscal year 2021.

***Net Income***

Net income was RMB109.8 million (US$15.9 million), compared with a net loss of RMB37.1 million in fiscal year 2021.

Adjusted net income was RMB122.9 million (US$17.8 million), compared with an adjusted net loss of RMB21.9 million in fiscal year 2021.

Basic and diluted net income per ADS were RMB2.06 (US$0.30) and RMB2.03 (US$0.29), respectively, compared with basic and diluted net loss per ADS of RMB0.69 in fiscal year 2021. Each ADS represents five Class A ordinary shares of the Company.

Adjusted diluted net income per ADS was RMB2.27 (US$0.33), compared with an adjusted diluted net loss per ADS of RMB0.41 in fiscal year 2021.

**<u>Exchange Rate Information</u>**

The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of December 30, 2022, which was RMB6.8972 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

**<u>Non-GAAP Financial Measures</u>**

iHuman considers and uses non-GAAP financial measures, such as adjusted operating income (loss), adjusted net income (loss) and adjusted diluted net income (loss) per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income (loss), adjusted net income (loss) and adjusted diluted net income (loss) per ADS as operating income (loss), net income (loss) and diluted net income (loss) per ADS excluding share-based compensation expenses, respectively. Adjusted operating income (loss), adjusted net income (loss) and adjusted diluted net income (loss) per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

**<u>Safe Harbor Statement</u>**

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

**About iHuman Inc.**

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-rearing experience easier for parents and transforming cognitive development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit <u>https://ir.ihuman.com/</u>.

**For investor and media enquiries, please contact:**

**iHuman Inc.**

Mr. Justin Zhang

Investor Relations Director

Phone: +86 10 5780-6606

E-mail: <u>ir@ihuman.com</u>

**Christensen**

In China

Mr. Eric Yuan

Phone: +86-13801110739

E-mail: <u>eric.yuan@christensencomms.com</u>

In the US

Ms. Linda Bergkamp

Phone: +1-480-614-3004

E-mail: <u>linda.bergkamp@christensencomms.com</u>

**iHuman Inc.**

**UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")**

**except for number of shares, ADSs** **, per share and per ADS data)**

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31,**<br>**2021** | **December 31,**<br>**2022** | **December 31,**<br>**2022** |
|  | **RMB** | **RMB** | **US$** |
| **ASSETS** |  |  |  |
| &nbsp;&nbsp;&nbsp;**Current assets** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | 855362 | 1049999 | 152236 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 56132 | 79614 | 11543 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 28054 | 19127 | 2773 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts due from related parties | 2845 | 2286 | 331 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepayments and other current assets | 72851 | 102765 | 14900 |
| &nbsp;&nbsp;&nbsp;**Total current assets** | **1015244** | **1253791** | **181783** |
| &nbsp;&nbsp;&nbsp;**Non-current assets** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Property and equipment, net | 12286 | 9205 | 1335 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Intangible assets, net | 27287 | 24872 | 3606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease right-of-use assets | 38237 | 12782 | 1853 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term investment |  | 26333 | 3818 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts due from related parties | 4223 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-current assets | 3604 | 6416 | 931 |
| &nbsp;&nbsp;&nbsp;**Total non-current assets** | **85637** | **79608** | **11543** |
| **Total assets** | **1100881** | **1333399** | **193326** |
| **LIABILITIES** |  |  |  |
| &nbsp;&nbsp;&nbsp;**Current liabilities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 30536 | 24206 | 3510 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue and customer advances | 302980 | 379063 | 54959 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amounts due to related parties | 8853 | 6944 | 1007 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 115895 | 144717 | 20982 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current operating lease liabilities | 24669 | 6123 | 888 |
| &nbsp;&nbsp;&nbsp;**Total current liabilities** | **482933** | **561053** | **81346** |
| &nbsp;&nbsp;&nbsp;**Non-current liabilities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-current operating lease liabilities | 9577 | 2894 | 420 |
| &nbsp;&nbsp;&nbsp;**Total non-current liabilities** | **9577** | **2894** | **420** |
| **Total liabilities** | **492510** | **563947** | **81766** |
| **SHAREHOLDERS' EQUITY** |  |  |  |
| &nbsp;&nbsp;&nbsp;Ordinary shares (par value of US$0.0001 per share, 700,000,000 Class A shares authorized as of December 31, 2021 and December 31, 2022; 125,122,382 Class A shares issued and 123,852,667 outstanding as of December 31, 2021; 125,122,382 Class A shares issued and 121,722,467 outstanding as of December 31, 2022; 200,000,000 Class B shares authorized, 144,000,000 Class B ordinary shares issued and outstanding as of December 31, 2021 and December 31, 2022; 100,000,000 shares (undesignated) authorized, nil shares (undesignated) issued and outstanding as of December 31, 2021 and December 31, 2022) | 185 | 185 | 27 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 1066052 | 1079099 | 156455 |
| &nbsp;&nbsp;&nbsp;Treasury stock | (164) | (7123) | (1033) |
| &nbsp;&nbsp;&nbsp;Statutory reserves | 606 | 7967 | 1155 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income (loss) | (34677) | 10497 | 1522 |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (423631) | (321173) | (46566) |
| **Total shareholders' equity** | **608371** | **769452** | **111560** |
| **Total liabilities and shareholders' equity** | **1100881** | **1333399** | **193326** |

---

**iHuman Inc.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")**

**except for number of shares, ADSs, per share and per ADS data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** | **For the three months ended** | **For the three months ended** | **For the year ended** | **For the year ended** | **For the year ended** |
|  | **December 31,**<br>**2021** | **September 30,**<br>**2022** | **December 31,**<br>**2022** | **December 31,**<br>**2022** | **December 31,**<br>**2021** | **December 31,**<br>**2022** | **December 31,**<br>**2022** |
|  | **RMB** | **RMB** | **RMB** | **US$** | **RMB** | **RMB** | **US$** |
| **Revenues** | **237822** | **251527** | **260704** | **37799** | **944722** | **985517** | **142887** |
| **Cost of revenues** | **(72913)** | **(74422)** | **(79707)** | **(11556)** | **(284098)** | **(294343)** | **(42676)** |
| **Gross profit** | **164909** | **177105** | **180997** | **26243** | **660624** | **691174** | **100211** |
| **Operating expenses** |  |  |  |  |  |  |  |
| Research and development expenses | (109081) | (71859) | (66796) | (9685) | (415334) | (313481) | (45450) |
| Sales and marketing expenses | (36652) | (41669) | (45811) | (6642) | (202093) | (156916) | (22751) |
| General and administrative expenses | (29751) | (25035) | (29253) | (4241) | (97445) | (109195) | (15832) |
| **Total operating expenses** | **(175484)** | **(138563)** | **(141860)** | **(20568)** | **(714872)** | **(579592)** | **(84033)** |
| **Operating income (loss)** | **(10575)** | **38542** | **39137** | **5675** | **(54248)** | **111582** | **16178** |
| Other income, net | 2691 | 9611 | 5315 | 771 | 17052 | 21190 | 3072 |
| **Income (loss) before income taxes** | **(7884)** | **48153** | **44452** | **6446** | **(37196)** | **132772** | **19250** |
| Income tax benefit (expenses) | (25) | (8675) | (9019) | (1308) | 145 | (22953) | (3328) |
| **Net income (loss)** | **(7909)** | **39478** | **35433** | **5138** | **(37051)** | **109819** | **15922** |
| **Net income (loss) per ADS:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;- Basic | (0.15) | 0.74 | 0.67 | 0.10 | (0.69) | 2.06 | 0.30 |
| &nbsp;&nbsp;&nbsp;&nbsp;- Diluted | (0.15) | 0.73 | 0.66 | 0.10 | (0.69) | 2.03 | 0.29 |
| **Weighted average number of ADSs:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;- Basic | 53331950 | 53240710 | 53205925 | 53205925 | 53326360 | 53307044 | 53307044 |
| &nbsp;&nbsp;&nbsp;&nbsp;- Diluted | 53331950 | 54114651 | 54033560 | 54033560 | 53326360 | 54040908 | 54040908 |
| **Total share-based compensation expenses included in:** |  |  |  |  |  |  |  |
| Cost of revenues | 172 | 77 | 168 | 24 | 940 | 348 | 50 |
| Research and development expenses | 220 | 2045 | 2564 | 372 | 5431 | 6377 | 925 |
| Sales and marketing expenses | 80 | 698 | 559 | 81 | 3010 | 1599 | 232 |
| General and administrative expenses | 1054 | 1187 | 1757 | 255 | 5794 | 4720 | 684 |

---

**iHuman Inc.**

**UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS**

**(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")**

**except for number of shares, ADSs, per share and per ADS data)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **For the three months ended** | **For the three months ended** | **For the three months ended** | **For the three months ended** | **For the year ended** | **For the year ended** | **For the year ended** |
|  | **December 31,**<br>**2021** | **September 30,**<br>**2022** | **December 31,**<br>**2022** | **December 31,**<br>**2022** | **December 31,**<br>**2021** | **December 31,**<br>**2022** | **December 31,**<br>**2022** |
|  | **RMB** | **RMB** | **RMB** | **US$** | **RMB** | **RMB** | **US$** |
| **Operating income (loss)** | **(10575)** | **38542** | **39137** | **5675** | **(54248)** | **111582** | **16178** |
| Share-based compensation expenses | 1526 | 4007 | 5048 | 732 | 15175 | 13044 | 1891 |
| **Adjusted operating income (loss)** | **(9049)** | **42549** | **44185** | **6407** | **(39073)** | **124626** | **18069** |
| **Net income (loss)** | **(7909)** | **39478** | **35433** | **5138** | **(37051)** | **109819** | **15922** |
| Share-based compensation expenses | 1526 | 4007 | 5048 | 732 | 15175 | 13044 | 1891 |
| **Adjusted net income (loss)** | **(6383)** | **43485** | **40481** | **5870** | **(21876)** | **122863** | **17813** |
| Diluted net income (loss) per ADS | (0.15) | 0.73 | 0.66 | 0.10 | (0.69) | 2.03 | 0.29 |
| Impact of non-GAAP adjustments | 0.03 | 0.07 | 0.09 | 0.01 | 0.28 | 0.24 | 0.04 |
| **Adjusted diluted net income (loss) per ADS** | **(0.12)** | **0.80** | **0.75** | **0.11** | **(0.41)** | **2.27** | **0.33** |
| Weighted average number of ADSs – diluted | 53331950 | 54114651 | 54033560 | 54033560 | 53326360 | 54040908 | 54040908 |
| **Weighted average number of ADSs – adjusted** | **53331950** | **54114651** | **54033560** | **54033560** | **53326360** | **54040908** | **54040908** |

---